Defining “cure” ⬇️

Finite ✅
Accessible ✅
Affordable ✅
Acceptable toxicity ✅
Disease does not come back in a certain percentage of patients treated after treatment is completed ✅

Clear and concise explanation by Dr Vincent Rajkumar 🙌🏻

At COMy I laid out my view on what the word Cure should mean in myeloma (and in cancer).

Dr Vincent Rajkumar of Mayo Clinic discusses highly anticipated abstracts in multiple myeloma that will be presented at the 2024 ASCO Annual Meeting. ASCO #ASCO24 #mmsm onclive.com/view/dr-rajkum…

The most impressive by Vincent Rajkumar is cure should not mean “unaffordable treatment that only a small population can afford (or access)”.

Multiple myeloma (MM) – subclonal, and not?

After talking to some colleagues, it occurs to me that it’s worthwhile making a clarification about the subclonal nature of MM.

What does this mean?
A short 🧵
1/x
#mmsm

This 👇👇👇👇from Vincent Rajkumar COMy Mayo Clinic
Wholeheartedly agree.
👇👇

Thanks Mohamad Mohty for taking the video.

It’s easy to redefine cure and make it easier to attain. But we shouldn’t. More here. The ASCO Post @ASCO

In the Friday's Gem 💎, we choose the NCI - ECOG E4A03, a trial led by Vincent Rajkumar which stands as an example of an academic study addressing a practical clinical question!

Check it out!👇
drugdevletter.com/p/low-dose-dex…

A massive thank you to Vincent Rajkumar for speaking with us today at #COMy2024 .

He discussed defining risk in myeloma, designing risk-based protocols, and shared his perspective on reaching a cure.

#MMsm #HemOnc COMy

Final day of a fantastic myeloma meeting organized by Mohamad Mohty
10th Annual COMy

Out now in Journal of Clinical Oncology! Our collaborative work:

𝐌𝐨𝐝𝐢𝐟𝐢𝐞𝐝 𝐒𝐭𝐚𝐠𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦 𝐟𝐨𝐫 𝐖𝐚𝐥𝐝𝐞𝐧𝐬𝐭𝐫ö𝐦 𝐦𝐚𝐜𝐫𝐨𝐠𝐥𝐨𝐛𝐮𝐥𝐢𝐧𝐞𝐦𝐢𝐚 (𝐌𝐒𝐒-𝐖𝐌)

ascopubs.org/doi/10.1200/JC…

Prashant Kapoor
Shaji Kumar Vincent Rajkumar Jithma Abeykoon, M.D. Jonas Paludo

A brief 🧵 1/

At COMy myeloma meeting with a couple of longtime friends and colleagues, Paul Richardson Dana-Farber and Antonio Palumbo GSK

COMy

THANK YOU all for your support to the ⁦COMy⁩ - What an incredible success! ⁦IACH⁩ ⁦International Myeloma Foundation⁩ ⁦Multiple Myeloma RF⁩ ⁦AF3M Asso⁩ ⁦Myeloma Society⁩ ⁦Vincent Rajkumar⁩ ⁦@MyelomaTeacher - Cindy Chmielewski⁩ ⁦Myeloma Patients Europe⁩ ⁦Meral Beksac⁩

In this episode of #OncLiveOnAir , experts from across oncology specialties discuss the abstracts and presentations they are most looking forward to seeing at the 2024 ASCO Meeting. Stephen V Liu, MD Sumanta K. Pal, MD, FASCO Dr. Shubham Pant Vincent Rajkumar #ASCO2024 onclive.com/view/oncology-…

⭐10th COMy Congress⭐️
Session 1
opens the scientific program with a session on:
Defining risk in myeloma
⏲️10:30 CET
🔽🔽
comylive.cme-congresses.com/lecture-hall/

Vincent Rajkumar . Shaji Kumar Eileen M. Boyle Mohamad Mohty Arnon Nagler marivi mateos

It's Official.

The agenda for the May 2024 AMA CPT® Editorial Panel Meeting includes a proposal to establish CPT codes for prior authorization + appeal of wrongful denials.

ama-assn.org/system/files/c…

#PriorAuthCPT #WrongfulDenialAppealCPT

1/15

Three friends and colleagues in the myeloma field

Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Memorial Sloan Kettering Cancer Center

Ken Anderson Dana-Farber
Shaji Kumar Mayo Clinic